Profile data is unavailable for this security.
About the company
Shaanxi Meibang Pharmaceutical Group Co Ltd is a company mainly engaged in the research and development (R&D), production and sales of pesticide preparations. The Company's products mainly include fungicides and pesticides. The fungicides include 80% dimethylmorpholine water dispersible granules, 27% chunleimycin bromonitrile wettable powder, 72% pyrazole ether ester combined water dispersible granules, 22% chunleimycin chlorobromoisocyanuric acid wettable powder, etc. The insecticides include 21% abamectin benzoate fenitrile suspension, 22% thiamethoxam beta cypermethrin suspension, 45% biphenyl hydrazide ethiconazole suspension, 20% fenitrile bifenthrin suspension, etc.
- Revenue in CNY (TTM)666.41m
- Net income in CNY32.72m
- Incorporated1998
- Employees939.00
- LocationShaanxi Meibang Pharmaceutical Group Co LtdHigh-Tech Industrial Development ZonePucheng County,XI'AN 715500ChinaCHN
- Phone+86 2 986183766
- Fax+86 2 989820615
- Websitehttp://www.meibang.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Soho Holly Corp | 7.27bn | 30.01m | 1.59bn | 715.00 | 53.11 | 0.754 | -- | 0.2193 | 0.1216 | 0.1216 | 29.46 | 8.57 | 1.28 | 41.85 | 6.64 | 10,168,320.00 | 1.01 | 0.8293 | 2.31 | 1.73 | 5.12 | 5.84 | 0.7882 | 0.7157 | 1.13 | -- | 0.3333 | 67.45 | 9.01 | 8.32 | -15.28 | -- | -20.69 | -- |
Panda Financial Holding Corp Ltd | 225.61m | -222.82m | 1.62bn | 114.00 | -- | 2.75 | -- | 7.17 | -1.34 | -1.34 | 1.36 | 3.54 | 0.2474 | 4.62 | 3.84 | 1,979,024.00 | -24.49 | -2.26 | -31.88 | -2.94 | 34.69 | 39.82 | -98.98 | -8.42 | 3.85 | -- | 0.1207 | -- | -30.66 | -4.22 | -335.01 | -- | -40.66 | -- |
Shandong Cynda Chemical Co Ltd | 2.42bn | -156.07m | 1.75bn | 2.18k | -- | 0.8773 | -- | 0.7209 | -0.3718 | -0.3718 | 5.62 | 4.58 | 0.6828 | 2.67 | 6.93 | 1,112,224.00 | -4.34 | 6.37 | -7.21 | 9.16 | 8.47 | 23.74 | -6.36 | 7.48 | 0.8941 | -- | 0.2825 | 35.64 | -20.58 | 8.70 | -125.68 | -- | -10.16 | -- |
Zhejiang Hisun Biomaterials Co Ltd | 802.46m | 46.30m | 1.75bn | 383.00 | 37.82 | 1.18 | -- | 2.18 | 0.2284 | 0.2284 | 3.96 | 7.34 | 0.4005 | 5.24 | 19.52 | 2,095,207.00 | 2.31 | -- | 2.84 | -- | 12.78 | -- | 5.77 | -- | 2.10 | -- | 0.2166 | -- | 24.43 | -- | -7.41 | -- | -- | -- |
Shaanxi Meibang Pharmaceuticl Grp Co Ltd | 666.41m | 32.72m | 1.75bn | 939.00 | 53.61 | 1.51 | -- | 2.63 | 0.2421 | 0.2421 | 4.93 | 8.57 | 0.4276 | 1.62 | 2.31 | 709,697.40 | 2.10 | 8.61 | 2.54 | 12.57 | 29.91 | 36.78 | 4.91 | 13.69 | 2.31 | -- | 0.0596 | 15.66 | -22.85 | 9.77 | -60.33 | -0.6051 | 42.34 | -- |
Suli Co Ltd | 1.89bn | -5.18m | 1.87bn | 1.58k | -- | 0.7563 | -- | 0.9906 | -0.0269 | -0.0269 | 10.43 | 13.76 | 0.349 | 4.61 | 6.12 | 1,197,981.00 | -0.1977 | 6.90 | -0.2914 | 10.61 | 11.52 | 23.64 | -0.5665 | 12.22 | 1.70 | -- | 0.3572 | 32.42 | -37.84 | 3.54 | -93.63 | -42.23 | 36.47 | -39.16 |
Data as of Jun 14 2024. Currency figures normalised to Shaanxi Meibang Pharmaceutical Group Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
Holder | Shares | % Held |
---|---|---|
Gfund Management Co., Ltd.as of 31 Dec 2023 | 735.90k | 2.18% |
Western Leadbank Fund Management Co., Ltdas of 31 Dec 2023 | 327.20k | 0.97% |
CITIC-Prudential Fund Management Co., Ltd.as of 31 Dec 2023 | 287.80k | 0.85% |
Lion Fund Management Co., Ltd.as of 31 Dec 2023 | 69.67k | 0.21% |
China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 47.17k | 0.14% |
China Southern Asset Management Co., Ltd.as of 30 Jun 2023 | 17.90k | 0.05% |
Guolian Fund Management Co. Ltd.as of 31 Dec 2023 | 16.00k | 0.05% |
Fortune & Royal Asset Management Co., Ltd.as of 31 Dec 2023 | 8.00k | 0.02% |
GF Fund Management Co., Ltd.as of 31 Dec 2023 | 6.50k | 0.02% |
ICBC Credit Suisse Asset Management Co., Ltd.as of 31 Dec 2023 | 3.32k | 0.01% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.